特刊：胃肠道癌症的诊断和预测性组织标志物
Special Issue: Diagnostic and Predictive Tissue Markers in G.I. Cancers.
作者信息
Chillotti Stefano, Vasuri Francesco
机构信息
Pathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
School of Anatomic Pathology, Department of Biomedical and Neuromotor Sciences, University of Bologna, 40123 Bologna, Italy.
出版信息
Cancers (Basel). 2023 Feb 20;15(4):1329. doi: 10.3390/cancers15041329.
Abstract
The compelling advancements in systemic targeted therapies for cancer drastically changed the role of histopathological analyses in recent decades [...].
摘要
近几十年来，癌症全身靶向治疗的重大进展极大地改变了组织病理学分析的作用[……]。
相似文献
1
Special Issue: Diagnostic and Predictive Tissue Markers in G.I. Cancers.特刊：胃肠道癌症的诊断和预测性组织标志物
Cancers (Basel). 2023 Feb 20;15(4):1329. doi: 10.3390/cancers15041329.
2
[Prognostic and predictive molecular markers for urologic cancers].[泌尿系统癌症的预后和预测分子标志物]
Urologe A. 2014 Apr;53(4):491-500. doi: 10.1007/s00120-014-3442-3.
3
HGF/MET pathway aberrations as diagnostic, prognostic, and predictive biomarkers in human cancers.HGF/MET 通路异常作为人类癌症的诊断、预后和预测生物标志物。
Crit Rev Clin Lab Sci. 2019 Dec;56(8):533-566. doi: 10.1080/10408363.2019.1653821. Epub 2019 Sep 12.
4
Predictive pathology in routine diagnostics of solid tumors.实体瘤常规诊断中的预测病理学。
Histol Histopathol. 2012 Mar;27(3):289-96. doi: 10.14670/HH-27.289.
5
The Evolving Role of Radiotherapy for Pediatric Cancers With Advancements in Molecular Tumor Characterization and Targeted Therapies.随着分子肿瘤特征分析和靶向治疗的进展，放射治疗在儿童癌症治疗中的作用不断演变。
Front Oncol. 2021 Sep 16;11:679701. doi: 10.3389/fonc.2021.679701. eCollection 2021.
6
A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.2015年预测性分子病理学及其在靶向癌症治疗中的作用更新：聚焦临床相关性的综述
Cancer Gene Ther. 2015 Sep;22(9):417-30. doi: 10.1038/cgt.2015.39. Epub 2015 Sep 11.
7
Circulating and Intracellular miRNAs as Prognostic and Predictive Factors in HER2-Positive Early Breast Cancer Treated with Neoadjuvant Chemotherapy: A Review of the Literature.循环和细胞内微小RNA作为新辅助化疗治疗HER2阳性早期乳腺癌的预后和预测因素：文献综述
Cancers (Basel). 2021 Sep 29;13(19):4894. doi: 10.3390/cancers13194894.
8
The Changing Paradigm for the Treatment of HER2-Positive Breast Cancer.人表皮生长因子受体2阳性乳腺癌治疗模式的转变
Cancers (Basel). 2020 Jul 28;12(8):2081. doi: 10.3390/cancers12082081.
9
Updates on breast biomarkers.乳腺生物标志物的最新进展
Virchows Arch. 2022 Jan;480(1):163-176. doi: 10.1007/s00428-022-03267-x. Epub 2022 Jan 14.
10
Current progress in systemic therapy for biliary tract cancers.胆道癌系统治疗的最新进展。
J Hepatobiliary Pancreat Sci. 2022 Oct;29(10):1094-1107. doi: 10.1002/jhbp.939. Epub 2021 Apr 5.
本文引用的文献
1
Correlation of molecular alterations with pathological features in hepatocellular carcinoma: Literature review and experience of an Italian center.肝细胞癌中分子改变与病理特征的相关性：文献复习及意大利中心经验
World J Gastroenterol. 2022 Jul 7;28(25):2854-2866. doi: 10.3748/wjg.v28.i25.2854.
2
Neuropilin-1 as a Potential Biomarker of Prognosis and Invasive-Related Parameters in Liver and Colorectal Cancer: A Systematic Review and Meta-Analysis of Human Studies.神经纤毛蛋白-1作为肝癌和结直肠癌预后及侵袭相关参数的潜在生物标志物：一项关于人体研究的系统评价和荟萃分析
Cancers (Basel). 2022 Jul 15;14(14):3455. doi: 10.3390/cancers14143455.
3
Tensin2 Is a Novel Diagnostic Marker in GIST, Associated with Gastric Location and Non-Metastatic Tumors.张力蛋白2是胃肠道间质瘤中的一种新型诊断标志物，与胃的位置及非转移性肿瘤相关。
Cancers (Basel). 2022 Jun 30;14(13):3212. doi: 10.3390/cancers14133212.
4
Evaluation of the Cell Block Method Using Overnight-Stored Bile for Malignant Biliary Stricture Diagnosis.使用过夜储存胆汁的细胞块法对恶性胆管狭窄诊断的评估
Cancers (Basel). 2022 May 30;14(11):2701. doi: 10.3390/cancers14112701.
5
Clinical Applications of Classical and Novel Biological Markers of Pancreatic Cancer.胰腺癌经典及新型生物标志物的临床应用
Cancers (Basel). 2022 Apr 7;14(8):1866. doi: 10.3390/cancers14081866.
6
Clinical Significance of Telomerase Reverse-Transcriptase Promoter Mutations in Hepatocellular Carcinoma.端粒酶逆转录酶启动子突变在肝细胞癌中的临床意义
Cancers (Basel). 2021 Jul 27;13(15):3771. doi: 10.3390/cancers13153771.
7
Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma.胆管癌和肝内胆管癌的局部区域治疗
Cancers (Basel). 2021 Jul 2;13(13):3336. doi: 10.3390/cancers13133336.
8
Mutations in key driver genes of pancreatic cancer: molecularly targeted therapies and other clinical implications.胰腺癌关键驱动基因的突变：分子靶向治疗及其它临床意义。
Acta Pharmacol Sin. 2021 Nov;42(11):1725-1741. doi: 10.1038/s41401-020-00584-2. Epub 2021 Feb 11.
9
NRP1 is a Prognostic Factor and Promotes the Growth and Migration of Cells in Intrahepatic Cholangiocarcinoma.神经纤毛蛋白1（NRP1）是肝内胆管癌的一个预后因素，并促进其细胞生长和迁移。
Cancer Manag Res. 2020 Aug 7;12:7021-7032. doi: 10.2147/CMAR.S260091. eCollection 2020.
10
Maintenance Olaparib for Germline -Mutated Metastatic Pancreatic Cancer.维持奥拉帕利治疗种系突变转移性胰腺癌。
N Engl J Med. 2019 Jul 25;381(4):317-327. doi: 10.1056/NEJMoa1903387. Epub 2019 Jun 2.
Zotero 插件